Staff Reporter
The Maharashtra government on Monday slashed the rate charged for the clinical testing for COVID-19 by ₹200, to bring it down to ₹980. This is the fourth cut announced by the State as the original cost of the test was ₹4,500.“While ₹980 will be levied by pathological laboratories, for tests conducted through laboratories at COVID-19 centres, hospitals, and quarantine centres, where a large number of samples are collected daily, ₹1,400 would be charged. Similarly, for testing samples collected
Staff Reporter
Maharashtra Deputy Chief Minister Ajit Pawar on Monday announced that he had tested positive for COVID-19. He is the 11th Cabinet minister from the Maha Vikas Aghadi government to have been infected with the virus. Mr. Pawar said, “I have tested positive for COVID-19, but my health is fine. I have been admitted to Breach Candy hospital after being advised by doctors. There is no need to worry. I will soon be active and will join you all after a brief rest.” The Deputy CM had been quarantined for
PTI
SEBI has barred Birla Pacific Medspa Ltd, Yashovardhan Birla and eight others from the securities market for two years for mis-utilisation of the IPO proceeds. Birla Pacific Medspa Ltd (BPML), which came out with offer documents in March 2011, had floated its over Rs 65-core initial public offering (IPO) in June 2011. The regulator found that the company made misstatements in the prospectus in respect of the objects of the IPO. While around 75% of the IPO proceeds were promised to be utilised
Ishan Patra
Several city residents took to Twitter to vent their ire about internet connectivity issues, flooding handles of broadband and mobile internet service providers.
